Eligix

Eligix, Inc. is a biopharmaceutical company engaged in the research and development of cell therapies. These therapies enhance the human immune response to cancer, autoimmune diseases, and solid organ transplantation; and reduce the risk of infection and allergic reactions during blood transfusions.